Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis

Condition:   Langerhans Cell HistiocytosisIntervention:   Drug: ClofarabineSponsors:   Dana-Farber Cancer Institute;   Sanofi;   St. Baldrick's Foundation;   Cookies for kids cancer foundationNot yet recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials